David DeLucia's most recent trade in FibroGen Inc was a trade of 2,325 Common Stock done at an average price of $0.4 . Disclosure was reported to the exchange on March 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
FibroGen Inc | David DeLucia | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 06 Mar 2025 | 2,325 | 116,137 (0%) | 0% | 0.4 | 907 | Common Stock |